These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1231 related items for PubMed ID: 19203856

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Myoclonic seizures in the context of generalized epilepsy with febrile seizures plus (GEFS+).
    Baulac M, Gourfinkel-An I, Baulac S, Leguern E.
    Adv Neurol; 2005; 95():119-25. PubMed ID: 15508917
    [No Abstract] [Full Text] [Related]

  • 44. A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures.
    Kimura K, Sugawara T, Mazaki-Miyazaki E, Hoshino K, Nomura Y, Tateno A, Hachimori K, Yamakawa K, Segawa M.
    Brain Dev; 2005 Sep; 27(6):424-30. PubMed ID: 16122630
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. SCN1A variant in a Scandinavian GEFS+ family: a wolf in sheep's clothing?
    Holland KD.
    Acta Neurol Scand; 2008 Nov; 118(5):344-5; author reply 346. PubMed ID: 18616623
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy.
    Claes L, Ceulemans B, Audenaert D, Smets K, Löfgren A, Del-Favero J, Ala-Mello S, Basel-Vanagaite L, Plecko B, Raskin S, Thiry P, Wolf NI, Van Broeckhoven C, De Jonghe P.
    Hum Mutat; 2003 Jun; 21(6):615-21. PubMed ID: 12754708
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation.
    Osaka H, Ogiwara I, Mazaki E, Okamura N, Yamashita S, Iai M, Yamada M, Kurosawa K, Iwamoto H, Yasui-Furukori N, Kaneko S, Fujiwara T, Inoue Y, Yamakawa K.
    Epilepsy Res; 2007 Jun; 75(1):46-51. PubMed ID: 17507202
    [Abstract] [Full Text] [Related]

  • 53. Recurrent de novo mutations of SCN1A in severe myoclonic epilepsy of infancy.
    Kearney JA, Wiste AK, Stephani U, Trudeau MM, Siegel A, RamachandranNair R, Elterman RD, Muhle H, Reinsdorf J, Shields WD, Meisler MH, Escayg A.
    Pediatr Neurol; 2006 Feb; 34(2):116-20. PubMed ID: 16458823
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Clinical spectrum of SCN2A mutations.
    Shi X, Yasumoto S, Kurahashi H, Nakagawa E, Fukasawa T, Uchiya S, Hirose S.
    Brain Dev; 2012 Aug; 34(7):541-5. PubMed ID: 22029951
    [Abstract] [Full Text] [Related]

  • 56. Does genotype determine phenotype? Sodium channel mutations in Dravet syndrome and GEFS+.
    Scheffer IE.
    Neurology; 2011 Feb 15; 76(7):588-9. PubMed ID: 21248272
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.
    Kanai K, Hirose S, Oguni H, Fukuma G, Shirasaka Y, Miyajima T, Wada K, Iwasa H, Yasumoto S, Matsuo M, Ito M, Mitsudome A, Kaneko S.
    Neurology; 2004 Jul 27; 63(2):329-34. PubMed ID: 15277629
    [Abstract] [Full Text] [Related]

  • 60. Genotype-phenotype associations in SCN1A-related epilepsies.
    Zuberi SM, Brunklaus A, Birch R, Reavey E, Duncan J, Forbes GH.
    Neurology; 2011 Feb 15; 76(7):594-600. PubMed ID: 21248271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.